Hong Wang Selected Research

Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)

2/2022	TNF-α increases the risk of bleeding in patients after CAR T-cell therapy: A bleeding model based on a real-world study of Chinese CAR T Working Party.
10/2021	Urinary Tumor Necrosis Factor-Like Weak Inducer of Apoptosis as a Biomarker for Diagnosis and Evaluating Activity in Lupus Nephritis: A Meta-analysis.
5/2021	The traditional Chinese medicine formula Fufang-Zhenzhu-Tiaozhi protects myocardia from injury in diabetic minipigs with coronary heart disease.
11/2020	Xueshuantong for Injection (Lyophilized, ) Alleviates Streptozotocin-Induced Diabetic Retinopathy in Rats.
10/2020	Bone marrow deficiency of mRNA decaying protein Tristetraprolin increases inflammation and mitochondrial ROS but reduces hepatic lipoprotein production in LDLR knockout mice.
12/2019	Intervention for early diabetic nephropathy by mesenchymal stem cells in a preclinical nonhuman primate model.
5/2019	Shuxuetong injection protects cerebral microvascular endothelial cells against oxygen-glucose deprivation reperfusion.
12/2018	Xueshuantong for Injection Ameliorates Diabetic Nephropathy in a Rat Model of Streptozotocin-Induced Diabetes.
3/2018	Expansion of human γδ T cells for adoptive immunotherapy using a bisphosphonate prodrug.
2/2018	Lack of association of tumor necrosis factor superfamily member 4 (TNFSF4) gene polymorphisms (rs3850641 and rs17568) with coronary heart disease and stroke: A systematic review and meta-analysis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hong Wang Research Topics

Disease

591	Neoplasms (Cancer) 12/2024 - 01/2001
214	Inflammation (Inflammations) 05/2024 - 04/2002
148	Infections 03/2024 - 01/2002
80	Cardiovascular Diseases (Cardiovascular Disease) 10/2023 - 05/2003
79	Neoplasm Metastasis (Metastasis) 04/2024 - 06/2004
79	Breast Neoplasms (Breast Cancer) 10/2023 - 10/2002
71	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 09/2004
57	Lung Neoplasms (Lung Cancer) 01/2024 - 09/2003
53	Hypoxia (Hypoxemia) 12/2024 - 02/2003
53	Fibrosis (Cirrhosis) 05/2024 - 10/2005
51	Atherosclerosis 08/2023 - 05/2003
50	Obesity 02/2024 - 09/2003
48	Carcinogenesis 01/2024 - 03/2006
45	Insulin Resistance 02/2023 - 09/2003
44	Prostatic Neoplasms (Prostate Cancer) 02/2024 - 10/2006
41	Body Weight (Weight, Body) 04/2024 - 01/2009
38	Wounds and Injuries (Trauma) 03/2024 - 06/2002
37	Adenocarcinoma of Lung 04/2024 - 09/2002
37	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2023 - 05/2012
36	Stroke (Strokes) 07/2023 - 11/2004
34	Type 2 Diabetes Mellitus (MODY) 10/2023 - 09/2003
34	Myocardial Infarction 01/2023 - 07/2006
32	Hyperlipidemias (Hyperlipidemia) 12/2023 - 11/2009
32	Pain (Aches) 11/2023 - 03/2002
31	Ischemia 02/2024 - 11/2007
31	Alzheimer Disease (Alzheimer's Disease) 12/2023 - 06/2004
31	Sepsis (Septicemia) 03/2022 - 01/2003
29	Thrombosis (Thrombus) 01/2023 - 04/2005
28	Melanoma (Melanoma, Malignant) 04/2024 - 01/2007
28	Hypertension (High Blood Pressure) 01/2022 - 12/2002
27	Colorectal Neoplasms (Colorectal Cancer) 08/2023 - 04/2011
25	Ischemic Stroke 03/2024 - 01/2008
25	Autoimmune Diseases (Autoimmune Disease) 01/2024 - 12/2004
24	Hemorrhage 11/2023 - 02/2002
23	COVID-19 03/2024 - 07/2020
23	Adenocarcinoma 03/2023 - 11/2003
22	Pneumonia (Pneumonitis) 04/2024 - 03/2006
21	Coronary Artery Disease (Coronary Atherosclerosis) 01/2023 - 06/2004
20	Heart Failure 03/2024 - 05/2012
20	Pneumococcal Infections 08/2023 - 03/2010
20	Disease Progression 06/2023 - 04/2006
19	Pancreatic Neoplasms (Pancreatic Cancer) 05/2024 - 08/2004
19	Glioma (Gliomas) 03/2024 - 01/2012
19	Mitochondrial Diseases (Mitochondrial Disease) 01/2024 - 07/2004
19	Carcinoma (Carcinomatosis) 01/2024 - 06/2003
19	Liver Diseases (Liver Disease) 11/2023 - 10/2012
19	Diabetes Mellitus 02/2023 - 11/2003
18	Colonic Neoplasms (Colon Cancer) 05/2024 - 11/2003
18	Rheumatoid Arthritis 04/2024 - 06/2004

Drug/Important Bio-Agent (IBA)

292	Proteins (Proteins, Gene)FDA Link 05/2024 - 01/2002
125	Biomarkers (Surrogate Marker)IBA 04/2024 - 10/2002
100	CytokinesIBA 01/2024 - 01/2003
71	MicroRNAs (MicroRNA)IBA 04/2024 - 01/2010
67	DNA (Deoxyribonucleic Acid)IBA 03/2024 - 12/2003
56	Messenger RNA (mRNA)IBA 02/2024 - 01/2002
53	Glucose (Dextrose)FDA LinkGeneric 02/2024 - 09/2003
52	EnzymesIBA 04/2024 - 01/2001
48	LipidsIBA 03/2024 - 07/2005
46	RNA (Ribonucleic Acid)IBA 05/2024 - 12/2003
40	Therapeutic UsesIBA 05/2024 - 06/2004
40	Long Noncoding RNAIBA 12/2023 - 09/2014
35	VaccinesIBA 12/2023 - 11/2006
34	Insulin (Novolin)FDA Link 10/2023 - 09/2003
33	Peptides (Polypeptides)IBA 01/2024 - 01/2004
33	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2023 - 04/2006
33	Interleukin-6 (Interleukin 6)IBA 10/2022 - 03/2008
31	LigandsIBA 11/2023 - 05/2002
30	Oxygen (Dioxygen)IBA 12/2024 - 10/2003
28	InflammasomesIBA 03/2024 - 01/2013
28	AntigensIBA 01/2023 - 11/2003
27	LipopolysaccharidesIBA 05/2024 - 08/2006
27	AntioxidantsIBA 11/2023 - 05/2009
27	Transcription Factors (Transcription Factor)IBA 08/2023 - 06/2003
23	CollagenIBA 05/2024 - 08/2004
23	Small Interfering RNA (siRNA)IBA 11/2023 - 02/2009
23	Polysaccharides (Glycans)IBA 02/2023 - 03/2010
22	CholesterolIBA 04/2024 - 05/2003
22	Circular RNAIBA 03/2024 - 01/2017
22	AntibodiesIBA 01/2024 - 01/2002
22	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2022 - 01/2004
21	Caspase 3 (Caspase-3)IBA 12/2024 - 01/2002
21	Indicators and Reagents (Reagents)IBA 05/2024 - 12/2003
21	CalciumIBA 02/2024 - 02/2007
21	InterferonsIBA 12/2023 - 03/2007
20	Anti-Bacterial Agents (Antibiotics)IBA 01/2024 - 01/2004
20	AcidsIBA 11/2023 - 04/2002
20	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2023 - 05/2005
19	Blood Glucose (Blood Sugar)IBA 04/2023 - 07/2005
19	Apolipoproteins E (ApoE)IBA 01/2023 - 09/2006
19	oxidized low density lipoproteinIBA 07/2022 - 05/2003

Therapy/Procedure

308	Therapeutics 12/2024 - 01/2001
69	Drug Therapy (Chemotherapy) 05/2024 - 06/2004
45	Immunotherapy 04/2024 - 11/2006
38	Transplantation 03/2024 - 02/2009
29	Aftercare (After-Treatment) 01/2024 - 02/2002
27	Extracorporeal Membrane Oxygenation 02/2024 - 04/2014
25	Chinese Traditional Medicine (Traditional Chinese Medicine) 05/2024 - 04/2002
24	Lasers (Laser) 01/2024 - 05/2003
22	Radiotherapy 12/2024 - 11/2004
19	Stents 06/2023 - 12/2005